i*******9
发帖数: 16 | 1 Jiangsu Hengrui Medicine （恒瑞医药） is a leading innovative pharmaceutical
company in China with annual sales of 4.55 billion Chinese Yuan in 2011 and
is poised to continue its growth in coming years. Under the leadership of
successful and experienced scientists and drug discovery veterans returning
from US/Europe, its R&D force now has over 800 scientists and has developed
the most robust innovative drug discovery pipeline in Chinese pharmaceutical
industry.
Hengrui’s R&D engine, Shanghai Hengrui （上海恒瑞）, is actively recruiting
quality scientists to lead/participate in exciting drug discovery efforts
in both small and large molecules. Qualified scientists should have a PhD
degree with/without postdoc experience in molecular biology/biochemistry or
related disciplines with successful track records. Scientists with in vivo
animal model, large molecule (protein and/or antibody) experience are highly
desirable. The candidates are expected to actively lead/engage in target
discovery, in vitro assay and in vivo animal model development and govern
drug discovery processes in a team oriented environment. These group leader
positions will be located in Shanghai, China with great compensation and
relocation packages.
Candidates with interest in joining Hengrui Pharmaceutical, please send your
letter/resumes to
Dr. Guoqing Cao, PhD
c***[email protected] |
|
